Review of atazanavir: a novel HIV protease inhibitor

Author： Fuster Daniel Clotet Bonaventura

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.9, 2005-08, pp. : 1565-1572

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atazanavir: a novel HIV-1 protease inhibitor

By Piliero Peter J

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1295-1301

Informa Healthcare

Access to resources Recommend Favorite

Tipranavir: A Novel Nonpeptidic Protease Inhibitor of HIV

By King Jennifer R. Acosta Edward P.

Clinical Pharmacokinetics, Vol. 45, Iss. 7, 2006-01 ,pp. : 665-682

Adis International

Access to resources Recommend Favorite

Atazanavir/ritonavir: a valuable once-daily HIV protease inhibitor with little impact on lipid profile

By Gianotti Nicola Lazzarin Adriano

Future Virology, Vol. 2, Iss. 2, 2007-03 ,pp. : 131-143

Future Medicine

Access to resources Recommend Favorite

Review of HIV-1 Protease Inhibitor Assay Methods

Current Pharmaceutical Analysis, Vol. 3, Iss. 3, 2007-08 ,pp. : 180-185

Bentham Science Publishers

Access to resources Recommend Favorite

Tipranavir: a novel non-peptidic protease inhibitor for the treatment of HIV infection

By Mehandru Saurabh Markowitz Martin

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1821-1828

Informa Healthcare

Access to resources Recommend Favorite